ALTERITY THERAPEUTICS LTD - SPONSORED ADS (ATHE)

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / SPONSORED ADS
Total 13F shares
58,438
Share change
-35,328
Total reported value
$163,168
Price per share
$2.79
Number of holders
7
Value change
-$98,105
Number of buys
1
Number of sells
2

Institutional Holders of ALTERITY THERAPEUTICS LTD - SPONSORED ADS (ATHE) as of Q2 2023

As of 30 Jun 2023 ALTERITY THERAPEUTICS LTD - SPONSORED ADS (ATHE) had 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 58,438 shares of stock of the company.
Largest 7 holders included MORGAN STANLEY, Twin Lakes Capital Management, LLC, Providence Capital Advisors, LLC, OSAIC HOLDINGS, INC., Sugarloaf Wealth Management, LLC, Coppell Advisory Solutions LLC, and Steward Partners Investment Advisory, LLC.
This table shows 7 institutional shareholders of the security as of 30 Jun 2023.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.